Cassava Sciences | PTIE - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Abbott USD 25.51B 488M 2026-03
Amgen USD 34.96B 3.49B 2026-06
Biogen USD 7.31B 1.88B 2026-06
Cara Therapeutics USD 25.33M 6.21M 2026-03
Cassava Sciences USD 87.96M 9.74M 2026-03
Eisai JPY 883.01B 121.38B 2026-06
Eli Lilly USD 64.67B 9.84B 2026-06
Geron USD 486.34M 12.19M 2026-06
J&J USD 59.77B 601M 2026-06
Merck USD 36.68B 1.66B 2026-06
Novartis USD 27.35B 744M 2026-06
Novavax USD 771.1M 79.72M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06